IL140628A - פרוקסטין מתנאוסלפונאט ותכשירי רוקחות המכילים אותו - Google Patents

פרוקסטין מתנאוסלפונאט ותכשירי רוקחות המכילים אותו

Info

Publication number
IL140628A
IL140628A IL14062899A IL14062899A IL140628A IL 140628 A IL140628 A IL 140628A IL 14062899 A IL14062899 A IL 14062899A IL 14062899 A IL14062899 A IL 14062899A IL 140628 A IL140628 A IL 140628A
Authority
IL
Israel
Prior art keywords
paroxetine
paroxetine methanesulfonate
solution
composition according
sodium starch
Prior art date
Application number
IL14062899A
Other languages
English (en)
Other versions
IL140628A0 (en
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269380&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL140628(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9814316.7A external-priority patent/GB9814316D0/en
Priority claimed from GBGB9821732.6A external-priority patent/GB9821732D0/en
Priority claimed from GBGB9902935.7A external-priority patent/GB9902935D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL140628A0 publication Critical patent/IL140628A0/xx
Publication of IL140628A publication Critical patent/IL140628A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14062899A 1998-07-02 1999-04-23 פרוקסטין מתנאוסלפונאט ותכשירי רוקחות המכילים אותו IL140628A (he)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds
GBGB9821732.6A GB9821732D0 (en) 1998-10-06 1998-10-06 Novel compound
GBGB9902935.7A GB9902935D0 (en) 1999-02-10 1999-02-10 Novel compound
PCT/GB1999/001253 WO2000001694A1 (en) 1998-07-02 1999-04-23 Paroxetine methanesulfonate

Publications (2)

Publication Number Publication Date
IL140628A0 IL140628A0 (en) 2002-02-10
IL140628A true IL140628A (he) 2004-06-20

Family

ID=27269380

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14062899A IL140628A (he) 1998-07-02 1999-04-23 פרוקסטין מתנאוסלפונאט ותכשירי רוקחות המכילים אותו

Country Status (35)

Country Link
US (4) US6063927A (he)
EP (5) EP1288214A1 (he)
JP (1) JP2002519422A (he)
KR (1) KR20010053336A (he)
CN (1) CN1127502C (he)
AR (2) AR011759A1 (he)
AT (4) AT3185U3 (he)
AU (4) AU713131B3 (he)
BE (3) BE1011664A6 (he)
BR (1) BR9911682A (he)
CA (1) CA2269999A1 (he)
CH (1) CH689805A8 (he)
DE (5) DE69911774T2 (he)
DK (7) DK199900554A (he)
ES (4) ES2149044T3 (he)
FI (2) FI112077B (he)
FR (2) FR2780728B1 (he)
GB (5) GB2336364B (he)
GR (3) GR990100140A (he)
HK (1) HK1037877A1 (he)
HU (1) HUP0102334A3 (he)
IE (5) IE20000633A1 (he)
IL (1) IL140628A (he)
IT (1) IT1312540B1 (he)
LU (1) LU90388B1 (he)
NL (4) NL1011874C1 (he)
NO (1) NO319030B1 (he)
NZ (1) NZ509180A (he)
PL (1) PL345214A1 (he)
PT (4) PT970955E (he)
SE (1) SE9901462A0 (he)
SI (3) SI1020464T1 (he)
SK (1) SK20262000A3 (he)
TR (1) TR200100054T2 (he)
WO (1) WO2000001694A1 (he)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
BR9807625A (pt) * 1997-02-27 2000-02-22 Ajinomoto Kk Aparelho e processo para cristalização.
PT994872E (pt) * 1997-06-10 2001-09-28 Synthon Bv Composto de 4-fenilpiperidina
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
US20040028582A1 (en) * 1999-03-10 2004-02-12 Smithkline Beecham Corporation Crystallization process for producing fine crystal products
USPP12225P2 (en) 1999-06-01 2001-11-27 Florfis Ag Geranium plant named ‘Fislamda’
AU5078700A (en) * 1999-06-22 2001-01-09 Smithkline Beecham Plc Novel composition
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
AU2001296084A1 (en) * 2000-08-28 2002-03-13 Synthon B.V. Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
CA2456233A1 (en) * 2001-08-02 2003-03-13 Spurcourt Limited Paroxetine isethionate salt, process of preparation and use in the treatment of depression
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
EP1778183B1 (en) * 2004-08-18 2018-06-27 Synthon B.V. Liquid paroxetine compositions
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
KR100672184B1 (ko) 2004-09-21 2007-01-19 주식회사종근당 파록세틴의 콜린산 또는 콜린산 유도체 염
CA2603832C (en) 2005-04-07 2011-11-22 Xy, Inc. Flow path conditioner system
US20070112031A1 (en) * 2005-11-14 2007-05-17 Gant Thomas G Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
EP1966192B1 (en) * 2005-12-01 2012-10-17 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
BRPI0808354A2 (pt) * 2007-03-09 2014-07-29 Novartis Ag Sais de 3-(1h-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quinazolin-4 -il]-pirrola-2,5-diona
US8119688B2 (en) * 2007-09-19 2012-02-21 Xy, Llc Differential evaporation potentiated disinfectant system
US20100249166A1 (en) 2007-09-19 2010-09-30 Xy, Inc. Differential evaporation potentiated disinfectant system
FR2926552B1 (fr) * 2008-01-23 2010-03-26 Biocodex Procede de preparation de particules de stiripentol ayant une granulometrie definie
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
US11111373B2 (en) 2018-12-05 2021-09-07 Chi Mei Corporation Polymethacrylate composition and optical device made therefrom, and display apparatus

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE99678C (he) *
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0190496A3 (en) * 1984-12-13 1987-05-27 Beecham Group Plc Piperidine derivatives having a gastro-intestinal activity
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
DE3677712D1 (de) * 1985-10-21 1991-04-04 Honda Motor Co Ltd Methode zur steuerung des spulenstroms eines magnetventils, das die saufluftmenge eines innenverbrennungsmotors steuert.
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
EP0269383A3 (en) * 1986-11-21 1990-05-02 A.H. Robins Company, Incorporated 1-Aryloxy-4-[(4-aryl)-1-piperazinyl]-2-butanols useful as antiallergy agents
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK716088D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
JP2773587B2 (ja) * 1992-11-30 1998-07-09 東レ株式会社 Ｏ，ｏ´−ジアシル酒石酸無水物の製造法
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
US5546683A (en) * 1993-09-29 1996-08-20 Clark; George J. Bucket attachment device with remote controlled retractable pins
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5668134A (en) * 1994-01-28 1997-09-16 G. D. Searle & Co. Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
CA2143070C (en) * 1994-02-22 2001-12-18 Pankaj Modi Oral controlled release liquid suspension pharmaceutical formulation
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
EP0818990A1 (en) * 1995-04-03 1998-01-21 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
AU721257B2 (en) * 1995-05-17 2000-06-29 Novo Nordisk A/S Process for preparing 4-aryl-piperidine derivatives
JP2813768B2 (ja) * 1995-05-24 1998-10-22 農林水産省家畜衛生試験場長 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
AU701386B2 (en) * 1995-10-31 1999-01-28 Merck & Co., Inc. Process for preparing substituted azetidinones
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
GB9526645D0 (en) * 1995-12-28 1996-02-28 Chiroscience Ltd Stereoselective synthesis
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
JP3446468B2 (ja) * 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
DE69739561D1 (de) * 1996-06-13 2009-10-15 Sumitomo Chemical Co Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride
PT994872E (pt) * 1997-06-10 2001-09-28 Synthon Bv Composto de 4-fenilpiperidina
SK11812000A3 (sk) * 1998-02-06 2001-08-06 Smithkline Beecham Plc Soli paroxetínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
EP1064282A1 (en) * 1998-03-16 2001-01-03 Smithkline Beecham Plc Crystalline form of paroxetine
ID26879A (id) * 1998-04-09 2001-02-15 Smithkline Beecham Plc Paroksetin maleat
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat

Also Published As

Publication number Publication date
AT3185U2 (de) 1999-11-25
DK200000390U1 (da) 2000-12-27
DE69911774T2 (de) 2004-08-05
BE1012420A6 (fr) 2000-10-03
CH689805A8 (fr) 2000-02-29
PT970955E (pt) 2000-11-30
EP1020463A1 (en) 2000-07-19
GB9909505D0 (en) 1999-06-23
NL1012272C1 (nl) 1999-07-12
DK0970955T3 (da) 2000-10-09
WO2000001694A1 (en) 2000-01-13
ES2158778A1 (es) 2001-09-01
DK199900234U1 (da) 2000-12-22
NO319030B1 (no) 2005-06-06
GR3034328T3 (en) 2000-12-29
GB9920332D0 (en) 1999-11-03
GB0119695D0 (en) 2001-10-03
GB0216752D0 (en) 2002-08-28
BE1011664A6 (fr) 1999-11-09
ATE202777T1 (de) 2001-07-15
SI1020464T1 (en) 2001-12-31
AU2392899A (en) 2000-01-20
CH689805A5 (fr) 1999-11-30
BE1012403A5 (fr) 2000-10-03
DK1089996T3 (da) 2004-02-09
FIU990190U0 (fi) 1999-04-23
FI990922A0 (fi) 1999-04-23
SE9901462L (he)
GB2336364A (en) 1999-10-20
IES20000894A2 (en) 2001-05-30
AU713131B3 (en) 1999-11-25
BR9911682A (pt) 2001-12-26
FR2780728B1 (fr) 2001-02-16
AU732211B2 (en) 2001-04-12
EP1020464B1 (en) 2001-07-04
DE29907248U1 (de) 1999-09-09
IT1312540B1 (it) 2002-04-22
DK1020464T3 (da) 2001-09-24
NL1012271A1 (nl) 1999-07-12
PT1089996E (pt) 2004-02-27
EP0970955B1 (en) 2000-08-02
SE9901462A0 (sv) 2000-01-03
AU713877B3 (en) 1999-12-09
PT102291B (pt) 2002-07-31
NL1011875C2 (nl) 2000-03-24
ES2158778B1 (es) 2002-03-16
HUP0102334A2 (hu) 2002-05-29
ATE195121T1 (de) 2000-08-15
US20020035130A1 (en) 2002-03-21
US6063927A (en) 2000-05-16
PT102291A (pt) 2000-05-31
SE9901462D0 (sv) 1999-04-23
GB2336364B (en) 2000-05-10
GB2339428A (en) 2000-01-26
AT3185U3 (de) 2000-01-25
US20020193406A1 (en) 2002-12-19
DE60000003T2 (de) 2002-03-21
NL1011874C1 (nl) 1999-07-12
DE69911774D1 (de) 2003-11-06
PL345214A1 (en) 2001-12-03
ITMI990866A1 (it) 2000-10-23
HUP0102334A3 (en) 2003-12-29
GB2377637A (en) 2003-01-22
GB2352395B (en) 2004-02-11
KR20010053336A (ko) 2001-06-25
AU732211C (en) 2004-05-06
NL1011875A1 (nl) 2000-01-07
AR011759A1 (es) 2000-09-13
SI1089996T1 (en) 2004-04-30
HK1037877A1 (en) 2002-02-22
GB0026487D0 (en) 2000-12-13
ES2149044T3 (es) 2000-10-16
FI990922A (fi) 2000-01-03
FI112077B (fi) 2003-10-31
EP0970955A1 (en) 2000-01-12
FR2802098A1 (fr) 2001-06-15
FI4209U1 (fi) 1999-11-10
EP1089996A1 (en) 2001-04-11
ATE251155T1 (de) 2003-10-15
CA2269999A1 (en) 2000-01-02
IES990343A2 (en) 2000-01-02
GR1003350B (el) 2000-03-29
JP2002519422A (ja) 2002-07-02
EP1020464A1 (en) 2000-07-19
DE19918588A1 (de) 2000-01-27
DK199900234U4 (da) 2000-12-22
AU3619199A (en) 2000-01-24
DK199900176U3 (da) 1999-08-13
NL1012271C2 (nl) 1999-09-23
TR200100054T2 (tr) 2001-06-21
GR3036208T3 (en) 2001-10-31
NZ509180A (en) 2001-06-29
LU90388B1 (fr) 2001-01-29
IE20000633A1 (en) 2001-10-17
ES2209428T3 (es) 2004-06-16
DE60000003D1 (de) 2001-08-09
NO991944D0 (no) 1999-04-23
PT1020464E (pt) 2001-10-30
IES20000893A2 (en) 2001-05-30
EP1288214A1 (en) 2003-03-05
GR990100140A (el) 2000-03-31
SK20262000A3 (sk) 2001-07-10
ES2157881T3 (es) 2001-09-01
GB2367003A (en) 2002-03-27
DE69900007D1 (de) 2000-09-07
IES81166B2 (en) 2000-05-31
FR2780728A1 (fr) 2000-01-07
IL140628A0 (en) 2002-02-10
EP1089996B1 (en) 2003-10-01
CN1315949A (zh) 2001-10-03
IE990344A1 (en) 2000-05-03
AR018197A1 (es) 2001-10-31
CN1127502C (zh) 2003-11-12
SI0970955T1 (en) 2001-02-28
NO991944L (no) 2000-01-03
GB2352395A (en) 2001-01-31
DE69900007T2 (de) 2001-06-07
US20010023253A1 (en) 2001-09-20
DK199900554A (da) 2000-01-03

Similar Documents

Publication Publication Date Title
EP0970955B1 (en) Paroxetine methanesulfonate
AU2002100370A4 (en) Novel compound
US20010023252A1 (en) Novel compound
AU2001100025A4 (en) Novel compound
AU724845B3 (en) Novel compound
AU732558B3 (en) Novel compound
AU5430701A (en) Novel compound
IES83541Y1 (en) Paroxetine methanesulfonate
MXPA01000307A (en) Paroxetine methanesulfonate
CZ20004924A3 (cs) Methansulfonat paroxetinu

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees